Table 2.
Bivariate analysis of factors associated with race data reporting.
| Race Information Reported |
p-value | ||
|---|---|---|---|
| No | Yes | ||
| Year Published | |||
| 2018 | 1 (100 %) | 0 (0 %) | 0.355 |
| 2019 | 1 (33.3 %) | 2 (66.7 %) | |
| 2020 | 2 (20 %) | 8 (80 %) | |
| 2021 | 2 (25 %) | 6 (75 %) | |
| 2022 | 6 (60 %) | 4 (40 %) | |
| 2023 | 4 (57.1 %) | 3 (42.9 %) | |
| 2024 | 2 (50 %) | 2 (50 %) | |
| USA study | |||
| No | 18 (69.2 %) | 8 (30.8 %) | <0.001 |
| Yes | 0 (0 %) | 16 (100 %) | |
| Multi-country study | |||
| No | 18 (51.4 %) | 17 (48.6 %) | 0.013 |
| Yes | 0 (0 %) | 8 (100 %) | |
| Pharmaceutical industry-sponsored study | |||
| No | 12 (66.7 %) | 6 (33.3 %) | 0.011 |
| Yes | 6 (24 %) | 19 (76 %) | |
| Recruited > 100 patients in the study | |||
| No | 11 (52.4 %) | 10 (47.6 %) | 0.223 |
| Yes | 7 (31.8 %) | 15 (68.2 %) | |